Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intrivo
Los Angeles, California, United States
- Ownership
- Private
- Employees
- ~200
- Development stage
- Other
01
Overview
Intrivo commercialized the On/Go rapid at-home antigen COVID-19 test and companion app in the U.S. during the pandemic; the product is fully commercial and widely distributed, but there is no public evidence of an internal therapeutic pipeline or traditional drug-development clinical trials[1][2][5].
- Therapeutic areas
- OtherInfectious Diseases
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
Partnerships with U.S. federal, state, and local governments for COVID-19 testing distribution[3][5].Collaborations with device makers, insurance companies, providers, and retailers to deploy the On/Go platform and tests[3][5].
Beyond the preview
Go deeper on Intrivo.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Intrivo.